NMK-89

N/A

Report date: 2025/09/19 17:52:09

Base Information

Drug NameNMK-89
Drug Alias NameNMK-89
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Zirconium > 89Zr +[4
Mechanisms of ActionMucin-5AC inhibitors
TargetsMucin-5AC
Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNihon Medi-Physics Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A